Moreover, the protective effects against atherosclerosis of IL-33 were hindered by combining it with a neutralizing anti-IL-5 antibody, indicating that the assistance provided by IL-33 in vivo is possibly mediated through an IL-5-driven response. This evidence concerns the gene IL33 and atherosclerosis.